1. Higher doses of insulin glargine linked to cancer

   Clinical study 16 February 2013 Pages: 1 - 1

2. Gardasil deemed “safe and effective” by Australian TGA

   News item 16 February 2013 Pages: 2 - 2

3. CHMP to review safety of Invirase, ARBs

   Media release 16 February 2013 Pages: 2 - 2

4. WHO releases Model Formulary for Children

   Media release 16 February 2013 Pages: 2 - 2

5. Misplaced concerns over safety of acid suppressants

   Clinical study 16 February 2013 Pages: 3 - 3

6. Over one-half of patients with bipolar disorder may continue to receive antidepressants,

   Clinical study 16 February 2013 Pages: 3 - 3

7. At the request of the US FDA, Pfizer has suspended its osteoarthritis (OA) clinical programme for tanezumab.

   Media release 16 February 2013 Pages: 3 - 3

8. Focus on biologicals at EULAR

   Meeting report 16 February 2013 Pages: 4 - 4

9. News from ASCO

   Meeting report 16 February 2013 Pages: 6 - 7

10. Safety of lisdexamfetamine assessed at APA

    Clinical study 16 February 2013 Pages: 7 - 7

11. Genetic testing may minimise liver injury risk for lumiracoxib

    Clinical study 16 February 2013 Pages: 7 - 7

12. Aceclofenac/celecoxib/indometacin

    Case report 16 February 2013 Pages: 8 - 8

13. Adalimumab/infliximab

    Case report 16 February 2013 Pages: 8 - 9

14. Alemtuzumab/methylprednisolone

    Case report 16 February 2013 Pages: 9 - 9

15. Allopurinol/furosemide

    Case report 16 February 2013 Pages: 9 - 9

16. Anaesthetics/labetalol

    Case report 16 February 2013 Pages: 9 - 9

17. Anakinra

    Case report 16 February 2013 Pages: 10 - 10

18. Anaesthetics/metronidazole

    Case report 16 February 2013 Pages: 10 - 10

19. Antipsychotics

    Case report 16 February 2013 Pages: 10 - 10

20. Aspirin/caffeine/paracetamol

    Case report 16 February 2013 Pages: 11 - 11

21. Benzylpenicillin

    Case report 16 February 2013 Pages: 11 - 11

22. Aspirin/warfarin

    Case report 16 February 2013 Pages: 11 - 11

23. Antiretrovirals

    Case report 16 February 2013 Pages: 11 - 11

24. Calcium

    Case report 16 February 2013 Pages: 12 - 12

25. Bupropion overdose

    Case report 16 February 2013 Pages: 12 - 12

26. Bevacizumab

    Case report 16 February 2013 Pages: 12 - 12

27. Carbimazole

    Case report 16 February 2013 Pages: 12 - 12

28. Clozapine

    Case report 16 February 2013 Pages: 13 - 13

29. Citalopram

    Case report 16 February 2013 Pages: 13 - 13

30. Chloroquine

    Case report 16 February 2013 Pages: 13 - 13

31. Clozapine

    Case report 16 February 2013 Pages: 13 - 13

32. Cyclophosphamide/doxorubicin

    Case report 16 February 2013 Pages: 14 - 14

33. Clozapine withdrawal

    Case report 16 February 2013 Pages: 14 - 14

34. Cotrimoxazole

    Case report 16 February 2013 Pages: 14 - 14

35. Dapsone

    Case report 16 February 2013 Pages: 14 - 14

36. Cyclopentolate

    Case report 16 February 2013 Pages: 14 - 14

37. Deferasirox

    Case report 16 February 2013 Pages: 15 - 15

38. Dexamethasone/prednisone

    Case report 16 February 2013 Pages: 15 - 15

39. Daptomycin

    Case report 16 February 2013 Pages: 15 - 15

40. Doxycycline

    Case report 16 February 2013 Pages: 16 - 16

41. Efavirenz/emtricitabine/tenofovir

    Case report 16 February 2013 Pages: 16 - 16

42. Digoxin overdose

    Case report 16 February 2013 Pages: 16 - 16

43. Epinephrine/salbutamol

    Case report 16 February 2013 Pages: 17 - 17

44. Efavirenz/lamivudine/zidovudine

    Case report 16 February 2013 Pages: 17 - 17

45. Etanercept

    Case report 16 February 2013 Pages: 17 - 17

46. Etretinate/prednisolone

    Case report 16 February 2013 Pages: 17 - 18

47. Fluticasone propionate/prednisolone

    Case report 16 February 2013 Pages: 18 - 18

48. Fluticasone propionate

    Case report 16 February 2013 Pages: 18 - 18

49. Fluorouracil/mitomycin

    Case report 16 February 2013 Pages: 18 - 18

50. Fentanyl

    Case report 16 February 2013 Pages: 18 - 18